Medpace Holdings, Inc. ($MEDP) CEO August J. Troendle sold 2,410 shares on September 28, 2026, at $620.07 per share. The open-market sale totaled $1,494,368.70. A Form 4 filed September 29, one day after the trade, reported his post-transaction ownership at 386,892 shares. Medpace operates in the Life Sciences Tools & Services sector and had a market capitalization near $17.2 billion. $MEDP shares closed at $615.94 on September 28.
The September 28 sale extended a run of open-market sales Troendle reported during September. On September 25, he sold 154 shares at $620.60 for $95,572.40. Two larger sales came earlier that week. On September 22, he sold 49,018 shares at $628.11, totaling $30,788,695.98. On September 21, he sold 21,883 shares at $623.29, totaling $13,639,455.07. Earlier September disclosures covered sales on September 17 (10,880 shares for $6,749,952.00), September 16 (8,770 shares for $5,448,713.30), and September 15 (15,971 shares for $9,915,435.64). The stock closed at $630.19 on September 22 and at $618.88 on September 25.
Troendle also reported open-market sales in August 2026. These included August 24 (1,983 shares for $1,229,916.09), August 21 (13,995 shares for $8,739,177.75), August 13 (458 shares for $274,978.62), August 12 (11,366 shares for $6,836,989.98), August 11 (17,610 shares for $10,655,987.10), and August 10 (5,534 shares for $3,328,867.02). The disclosure history on the ticker reaches back into 2025, with December sales on December 1 (23,178 shares for $13,750,348.50), December 2 (5,698 shares for $3,364,498.06), and December 3 (668 shares for $394,580.92).
Other Medpace insiders filed sale disclosures during 2026. Director Robert O. Kraft sold 3,858 shares on August 26 at $617.81, totaling $2,383,510.98. Director Cornelius P. McCarthy III sold 795 shares on August 7 at $585.07, totaling $465,131.45. President Jesse J. Geiger sold 31,707 shares on March 17 at $455.30, totaling $14,436,197.10.
Congressional disclosures have also referenced $MEDP. Representative David J. Taylor, a Republican, reported a purchase of Medpace shares on May 15, 2026, disclosed on May 28, with a midpoint value of $1,001. Congressional dollar figures are midpoint estimates of bracketed disclosure ranges rather than exact amounts. Taylor also reported earlier Medpace transactions in January and February 2026. Representative Gilbert Cisneros, a Democrat, reported a sale on January 15, 2026, disclosed February 13, with a midpoint value of $15,001. Representative Lisa Mcclain, a Republican, reported a sale on August 4, 2025, disclosed September 12, with a midpoint value of $1,001. Cisneros also reported sales in October 2025 (disclosed November 18, midpoint $1,001) and July 2025 (disclosed August 14, midpoint $1,001). Mcclain reported a purchase on July 22, 2025, disclosed August 13, midpoint $1,001.
The September 28 filing was the most recent entry in Troendle's longer disclosure history on the ticker. Across the seven open-market sales Troendle disclosed from September 15 through September 28, the combined value was about $68.1 million.